Molecular Genetics & Genomic Medicine (Apr 2022)

Comprehensive variant calling from whole‐genome sequencing identifies a complex inversion that disrupts ZFPM2 in familial congenital diaphragmatic hernia

  • Thomas J. Nicholas,
  • Najla Al‐Sweel,
  • Andrew Farrell,
  • Rong Mao,
  • Pinar Bayrak‐Toydemir,
  • Christine E. Miller,
  • Dawn Bentley,
  • Rachel Palmquist,
  • Barry Moore,
  • Edgar J. Hernandez,
  • Michael J. Cormier,
  • Eric Fredrickson,
  • Katherine Noble,
  • Shawn Rynearson,
  • Carson Holt,
  • Mary Anne Karren,
  • Joshua L. Bonkowsky,
  • Martin Tristani‐Firouzi,
  • Mark Yandell,
  • Gabor Marth,
  • Aaron R. Quinlan,
  • Luca Brunelli,
  • Reha M. Toydemir,
  • Brian J. Shayota,
  • John C. Carey,
  • Steven E. Boyden,
  • Sabrina Malone Jenkins

DOI
https://doi.org/10.1002/mgg3.1888
Journal volume & issue
Vol. 10, no. 4
pp. n/a – n/a

Abstract

Read online

Abstract Background Genetic disorders contribute to significant morbidity and mortality in critically ill newborns. Despite advances in genome sequencing technologies, a majority of neonatal cases remain unsolved. Complex structural variants (SVs) often elude conventional genome sequencing variant calling pipelines and will explain a portion of these unsolved cases. Methods As part of the Utah NeoSeq project, we used a research‐based, rapid whole‐genome sequencing (WGS) protocol to investigate the genomic etiology for a newborn with a left‐sided congenital diaphragmatic hernia (CDH) and cardiac malformations, whose mother also had a history of CDH and atrial septal defect. Results Using both a novel, alignment‐free and traditional alignment‐based variant callers, we identified a maternally inherited complex SV on chromosome 8, consisting of an inversion flanked by deletions. This complex inversion, further confirmed using orthogonal molecular techniques, disrupts the ZFPM2 gene, which is associated with both CDH and various congenital heart defects. Conclusions Our results demonstrate that complex structural events, which often are unidentifiable or not reported by clinically validated testing procedures, can be discovered and accurately characterized with conventional, short‐read sequencing and underscore the utility of WGS as a first‐line diagnostic tool.